Torres Oscar V, Jayanthi Subramanian, Ladenheim Bruce, McCoy Michael T, Krasnova Irina N, Cadet Jean Lud
Molecular Neuropsychiatry Research Branch, DHHS/NIH/NIDA Intramural Research Program, 251 Bayview Boulevard, Baltimore, MD 21224, United States.
Molecular Neuropsychiatry Research Branch, DHHS/NIH/NIDA Intramural Research Program, 251 Bayview Boulevard, Baltimore, MD 21224, United States.
Behav Brain Res. 2017 May 30;326:265-271. doi: 10.1016/j.bbr.2017.03.009. Epub 2017 Mar 9.
Methamphetamine (METH) addicts lose control over drug consumption despite suffering multiple adverse medicolegal consequences. To mimic the negative events associated with drug addiction in humans, we recently introduced a rat model of self-administration (SA) with response-contingent punishment on METH intake. These procedures allowed us to distinguish between two addiction-like phenotypes in rats, those that sustained METH taking despite negative consequences (shock-resistant, SR) and rats that significantly reduced their METH intake (shock-sensitive, SS). Here, we further developed our adverse consequence model and examined incubation of METH craving by measuring cue-induced drug seeking in SR and SS rats. Male Sprague-Dawley rats were trained to self-administer METH (0.1mg/kg/injection) or saline intravenously (i.v.) during twenty-two 9-h sessions that consisted of 3 separate 3-h sessions separated by 30min. Subsequently, rats were subjected to incremental footshocks during thirteen additional 9-h METH SA sessions performed in a fashion identical to the training phase. Cue-induced drug craving was then assessed at 2 and 21days after the footshock phase. All rats escalated their intake of METH, with both phenotypes showing similar drug taking patterns during SA training. In addition, rats that continued their METH intake despite negative consequences showed even greater cue-induced drug craving following withdrawal than the rats that reduced METH intake following negative consequences. Taken together, our adverse consequence-based model highlights the possibility of identifying rats by addiction-like phenotypes and subsequent vulnerability to relapse-like behaviors. The use of similar SA models should help in the development of better therapeutic approaches to treat different stages of METH addiction.
尽管甲基苯丙胺(METH)成瘾者会遭受多种不良的医学法律后果,但他们仍无法控制药物的使用。为了模拟与人类药物成瘾相关的负面事件,我们最近引入了一种甲基苯丙胺自我给药(SA)大鼠模型,该模型对甲基苯丙胺的摄入进行反应性惩罚。这些程序使我们能够区分大鼠的两种成瘾样表型,即那些尽管有负面后果仍持续摄入甲基苯丙胺的大鼠(抗电击,SR)和那些显著减少甲基苯丙胺摄入量的大鼠(电击敏感,SS)。在这里,我们进一步完善了我们的不良后果模型,并通过测量线索诱导的觅药行为,在SR和SS大鼠中研究了甲基苯丙胺渴望的潜伏期。雄性Sprague-Dawley大鼠在22个9小时的实验中接受训练,通过静脉注射(i.v.)自我给药甲基苯丙胺(0.1mg/kg/注射)或生理盐水,实验由3个单独的3小时实验组成,中间间隔30分钟。随后,在另外13个9小时的甲基苯丙胺SA实验中,以与训练阶段相同的方式对大鼠施加递增的足部电击。然后在足部电击阶段后的第2天和第21天评估线索诱导的药物渴望。所有大鼠的甲基苯丙胺摄入量都有所增加,两种表型在SA训练期间表现出相似的药物摄入模式。此外,尽管有负面后果仍继续摄入甲基苯丙胺的大鼠在戒断后比那些因负面后果而减少甲基苯丙胺摄入量的大鼠表现出更强烈的线索诱导的药物渴望。综上所述,我们基于不良后果的模型突出了通过成瘾样表型识别大鼠以及随后对复发样行为易感性的可能性。使用类似的SA模型应该有助于开发更好的治疗方法来治疗甲基苯丙胺成瘾的不同阶段。